LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 109

Search options

  1. Article ; Online: Congenital disorders of intestinal digestion and absorption (sugars, proteins, lipids, ions).

    Peretti, Noel / Mas, Emmanuel

    Best practice & research. Clinical gastroenterology

    2022  Volume 56-57, Page(s) 101785

    Abstract: Congenital diarrhea may result from 2 main different mechanisms: 1) osmotic diarrhea is caused by the non-digestion-absorption of nutrients leading to the non-absorbed nutrients going into the lumen, increasing the osmotic force and driving fluids; 2) ... ...

    Abstract Congenital diarrhea may result from 2 main different mechanisms: 1) osmotic diarrhea is caused by the non-digestion-absorption of nutrients leading to the non-absorbed nutrients going into the lumen, increasing the osmotic force and driving fluids; 2) secretory diarrhea induced by the inhibition of intestinal absorption of electrolytes, increasing electrolyte and water flux towards the intestinal lumen. The malabsorption of macronutrients (carbohydrates, proteins and lipids) induces energy deficiency with symptoms depending on the macronutrient: carbohydrates with watery acidic diarrhea; protein with rapid malnutrition, edema, and hypoalbuminemia; and lipids with malnutrition, steatorrhea and hypocholesterolemia. Ionic malabsorption (Cl and Na) is responsible for severe and rapid dehydration sometimes with prenatal abnormalities (polyhydramnios and bowel dilatation).
    MeSH term(s) Digestion/physiology ; Female ; Humans ; Intestines ; Ions ; Lipids ; Pregnancy ; Sugars
    Chemical Substances Ions ; Lipids ; Sugars
    Language English
    Publishing date 2022-02-05
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2048181-0
    ISSN 1532-1916 ; 1521-6918
    ISSN (online) 1532-1916
    ISSN 1521-6918
    DOI 10.1016/j.bpg.2022.101785
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: New Classification and Management of Abetalipoproteinemia and Related Disorders.

    Bredefeld, Cindy / Peretti, Noel / Hussain, M Mahmood

    Gastroenterology

    2020  Volume 160, Issue 6, Page(s) 1912–1916

    MeSH term(s) Abetalipoproteinemia/classification ; Abetalipoproteinemia/diagnosis ; Apolipoprotein B-100/genetics ; Female ; Humans ; Hyperlipidemia, Familial Combined/diagnosis ; Hypobetalipoproteinemia, Familial, Apolipoprotein B/classification ; Hypobetalipoproteinemia, Familial, Apolipoprotein B/diagnosis ; Hypobetalipoproteinemias/classification ; Hypobetalipoproteinemias/diagnosis ; Hypobetalipoproteinemias/genetics ; Hypobetalipoproteinemias/therapy ; Malabsorption Syndromes/diagnosis ; Pregnancy ; Pregnancy Complications/etiology
    Chemical Substances APOB protein, human ; Apolipoprotein B-100
    Language English
    Publishing date 2020-12-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80112-4
    ISSN 1528-0012 ; 0016-5085
    ISSN (online) 1528-0012
    ISSN 0016-5085
    DOI 10.1053/j.gastro.2020.11.040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Treatment of pediatric heterozygous familial hypercholesterolemia 7 years after the EAS recommendations: Real-world results from a large French cohort.

    Peretti, Noel / Vimont, Alexandre / Mas, Emmanuel / Lemale, Julie / Reynaud, Rachel / Tounian, Patrick / Poinsot, Pierre / Restier, Liora / Paillard, François / Pradignac, Alain / Pucheu, Yann / Rabès, Jean-Pierre / Bruckert, Eric / Gallo, Antonio / Béliard, Sophie

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

    2024  Volume 31, Issue 3, Page(s) 188–194

    Abstract: Background: Heterozygous familial hypercholesterolemia (HeFH) predisposes to premature cardiovascular diseases. Since 2015, the European Atherosclerosis Society has advocated initiation of statins at 8-10 years of age and a low-density lipoprotein ... ...

    Abstract Background: Heterozygous familial hypercholesterolemia (HeFH) predisposes to premature cardiovascular diseases. Since 2015, the European Atherosclerosis Society has advocated initiation of statins at 8-10 years of age and a low-density lipoprotein cholesterol (LDL-C) target of <135 mg/dL. Longitudinal data from large databases on pharmacological management of pediatric HeFH are lacking.
    Objective: Here, we describe treatment patterns and LDL-C goal attainment in pediatric HeFH using longitudinal real-world data.
    Methods: This was a retrospective and prospective multicenter cohort study (2015-2021) of children with HeFH, diagnosed genetically or clinically, aged <18 years, and followed up in the National French Registry of FH (REFERCHOL). Data on the study population as well as treatment patterns and outcomes are summarized as mean±SD.
    Results: We analyzed the data of 674 HeFH children (age at last visit: 13.1 ± 3.6 years; 82.0 % ≥10 years; 52.5 % females) who were followed up for a mean of 2.8 ± 3.5 years. Initiation of lipid-lowering therapy was on average at 11.8 ± 3.0 years of age for a duration of 2.5 ± 2.8 years. At the last visit, among patients eligible for treatment (573), 36 % were not treated, 57.1 % received statins alone, 6.4 % statins with ezetimibe, and 0.2 % ezetimibe alone. LDL-C was 266±51 mg/dL before treatment and 147±54 mg/dL at the last visit (-44.7 %) in treated patients. Regarding statins, 3.3 %, 65.1 %, and 31.6 % of patients received high-, moderate-, and low-intensity statins, respectively. Overall, 59 % of children on statin therapy alone and 35.1 % on bitherapy did not achieve the LDL-C goal; fewer patients in the older age group did not reach the treatment goal.
    Conclusion: Pediatric patients with FH followed up in specialist lipid clinics in France receive late treatment, undertreatment, or suboptimal treatment and half of them do not reach the therapeutic LDL-C goal. Finding a more efficient framework for linking scientific evidence to clinical practice is needed.
    MeSH term(s) Adolescent ; Child ; Female ; Humans ; Male ; Anticholesteremic Agents/therapeutic use ; Cholesterol, LDL/therapeutic use ; Cohort Studies ; Ezetimibe/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hypercholesterolemia ; Hyperlipoproteinemia Type II/drug therapy ; Hyperlipoproteinemia Type II/epidemiology ; Prospective Studies ; Retrospective Studies
    Chemical Substances Anticholesteremic Agents ; Cholesterol, LDL ; Ezetimibe (EOR26LQQ24) ; Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Language English
    Publishing date 2024-03-27
    Publishing country France
    Document type Multicenter Study ; Journal Article
    ZDB-ID 1181947-9
    ISSN 1769-664X ; 0929-693X
    ISSN (online) 1769-664X
    ISSN 0929-693X
    DOI 10.1016/j.arcped.2024.01.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The emerging connections between IGF1, the intestinal microbiome,

    Poinsot, Pierre / Schwarzer, Martin / Peretti, Noël / Leulier, François

    Journal of molecular endocrinology

    2018  Volume 61, Issue 1, Page(s) T103–T113

    Abstract: In most animal species, postnatal growth is controlled by conserved insulin/insulin-like growth factor (IGF) signaling. In mammals, juvenile growth is characterized by a longitudinal bone growth resulting from the ossification of the growth plate. This ... ...

    Abstract In most animal species, postnatal growth is controlled by conserved insulin/insulin-like growth factor (IGF) signaling. In mammals, juvenile growth is characterized by a longitudinal bone growth resulting from the ossification of the growth plate. This ossification is under IGF1 influence through endocrine and paracrine mechanisms. Moreover, the nutritional status has been largely described as an important factor influencing the insulin/insulin-like growth factor signaling. It is now well established that the gut microbiota modulates the nutrient availability of its host. Hence, studies of the interaction between nutritional status, gut microbiota and bone growth have recently emerged. Here, we review recent findings using experimental models about the impact of gut bacteria on the somatotropic axis and its consequence on the bone growth. We also discuss the perspectives of these studies in opening an entire field for clinical interventions.
    MeSH term(s) Animals ; Gastrointestinal Microbiome/physiology ; Humans ; Insulin-Like Growth Factor I/metabolism ; Intercellular Signaling Peptides and Proteins/metabolism ; Lactobacillus/metabolism
    Chemical Substances Intercellular Signaling Peptides and Proteins ; Insulin-Like Growth Factor I (67763-96-6)
    Language English
    Publishing date 2018-05-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 645012-x
    ISSN 1479-6813 ; 0952-5041
    ISSN (online) 1479-6813
    ISSN 0952-5041
    DOI 10.1530/JME-17-0292
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Undernourished patients do not have increased risk of severe COVID-19 outcomes.

    Fneich, Ahmad / Poinsot, Pierre / Elias, Christelle / Restier, Lioara / Vanhems, Philippe / Wallet, Florent / Caussy, Cyrielle / Duclos, Antoine / Peretti, Noël

    Clinical nutrition open science

    2022  Volume 44, Page(s) 9–14

    Abstract: Background: Undernutrition has been previously identified as a deleterious factor in acute infections. In covid-19 infection, obesity is a risk-factor of severe evolution, but initial undernutrition has not been evaluated yet.: Methods: We ... ...

    Abstract Background: Undernutrition has been previously identified as a deleterious factor in acute infections. In covid-19 infection, obesity is a risk-factor of severe evolution, but initial undernutrition has not been evaluated yet.
    Methods: We retrospectively analyzed correlation between nutritional status at admission and severe outcomes (intensive care unit admission, invasive mechanical ventilation requirement and death) of patients hospitalized for confirmed covid-19 infection.
    Results: Risk of intensive care unit admission and invasive mechanical ventilation requirement was not significantly different between undernutrition and normoweight sub-groups, but increased in excessive weight sub-group (ODDR (IC 95%) 1.048 (1.011-1.086), p = 0.011). Risk of death was the same in all sub-groups.
    Conclusion: Undernutrition didn't appear as a factor of severe outcomes in covid-19 infection.
    Language English
    Publishing date 2022-03-31
    Publishing country United States
    Document type Journal Article
    ISSN 2667-2685
    ISSN (online) 2667-2685
    DOI 10.1016/j.nutos.2022.03.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Therapeutic Approach of Very Early-Onset Inflammatory Bowel Disease in a Loeys-Dietz Syndrome Child.

    Opréa, Alina / Collardeau-Frachon, Sophie / Heissat, Sophie / Peretti, Noel / Lachaux, Alain / Duclaux-Loras, Rémi

    JPGN reports

    2021  Volume 3, Issue 1, Page(s) e139

    Abstract: Heterozygous TGFBR2 loss-of-function mutation is an extremely rare cause of very-early onset inflammatory bowel disease (VEOIBD) as, so far, only three cases have been reported in the literature. VEOIBD therapeutic management remains a real challenge for ...

    Abstract Heterozygous TGFBR2 loss-of-function mutation is an extremely rare cause of very-early onset inflammatory bowel disease (VEOIBD) as, so far, only three cases have been reported in the literature. VEOIBD therapeutic management remains a real challenge for clinicians. Here, we described an interesting new case of Loeys-Dietz syndrome presenting severe, very early intestinal inflammation associated with dysmorphic features, aortic arch tortuosity joint hyper laxity and severe scoliosis. TGFBR2 Sanger sequencing revealed a missense mutation c.1583G>A (p.Arg528His). As endoscopy confirmed a severe colitis, we chose a classical IBD therapeutic approach. We finally obtained remission under Ustekinumab (90 mg/6 weeks).
    Language English
    Publishing date 2021-12-10
    Publishing country United States
    Document type Case Reports
    ISSN 2691-171X
    ISSN (online) 2691-171X
    DOI 10.1097/PG9.0000000000000139
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Validation of Knock-Out Caco-2 TC7 Cells as Models of Enterocytes of Patients with Familial Genetic Hypobetalipoproteinemias.

    Bordat, Claire / Vairo, Donato / Cuerq, Charlotte / Halimi, Charlotte / Peiretti, Franck / Penhoat, Armelle / Vieille-Marchiset, Aurélie / Gonzalez, Teresa / Michalski, Marie-Caroline / Nowicki, Marion / Peretti, Noël / Reboul, Emmanuelle

    Nutrients

    2023  Volume 15, Issue 3

    Abstract: Abetalipoproteinemia (FHBL-SD1) and chylomicron retention disease (FHBL-SD3) are rare recessive disorders of lipoprotein metabolism due to mutations ... ...

    Abstract Abetalipoproteinemia (FHBL-SD1) and chylomicron retention disease (FHBL-SD3) are rare recessive disorders of lipoprotein metabolism due to mutations in
    MeSH term(s) Humans ; alpha-Tocopherol ; Apolipoproteins B/genetics ; Caco-2 Cells ; Enterocytes/metabolism ; Hypobetalipoproteinemias/genetics ; Hypobetalipoproteinemias/metabolism ; Monomeric GTP-Binding Proteins/metabolism ; Vitamin E/pharmacology
    Chemical Substances alpha-Tocopherol (H4N855PNZ1) ; Apolipoproteins B ; Monomeric GTP-Binding Proteins (EC 3.6.5.2) ; SAR1B protein, human (EC 3.6.1.-) ; Vitamin E (1406-18-4)
    Language English
    Publishing date 2023-01-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu15030505
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Closure of residual fistula after esophageal atresia repair in a 5-year-old using endoscopic submucosal dissection of surrounding mucosa.

    Lavaud, Grégoire / Heissat, Sophie / Chauveau, Auxane / Peretti, Noël / Lachaux, Alain / Oung, Borathchakra / Pioche, Mathieu

    Endoscopy

    2020  Volume 53, Issue 4, Page(s) E132–E133

    MeSH term(s) Child, Preschool ; Endoscopic Mucosal Resection/adverse effects ; Esophageal Atresia/surgery ; Esophageal Neoplasms ; Humans ; Mucous Membrane ; Tracheoesophageal Fistula/etiology ; Tracheoesophageal Fistula/surgery
    Language English
    Publishing date 2020-08-05
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 80120-3
    ISSN 1438-8812 ; 0013-726X
    ISSN (online) 1438-8812
    ISSN 0013-726X
    DOI 10.1055/a-1216-0271
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Carotenoids in familial hypobetalipoproteinemia disorders: Malabsorption in Caco2 cell models and severe deficiency in patients.

    Bordat, Claire / Cuerq, Charlotte / Halimi, Charlotte / Vairo, Donato / Blond, Emilie / Restier, Liora / Poinsot, Pierre / Duclaux-Loras, Rémi / Peretti, Noël / Reboul, Emmanuelle

    Journal of clinical lipidology

    2023  Volume 18, Issue 1, Page(s) e105–e115

    Abstract: Background: Familial hypobetalipoproteinemias (FHBL) are rare genetic diseases characterized by lipid malabsorption. We focused on abetalipoproteinemia (FHBL-SD1) and chylomicron retention disease (FHBL-SD3), caused by mutations in microsomal ... ...

    Abstract Background: Familial hypobetalipoproteinemias (FHBL) are rare genetic diseases characterized by lipid malabsorption. We focused on abetalipoproteinemia (FHBL-SD1) and chylomicron retention disease (FHBL-SD3), caused by mutations in microsomal triglyceride transfer protein (MTTP) and SAR1B genes, respectively. Treatments include a low-fat diet and high-dose fat-soluble vitamin supplementations. However, patients are not supplemented in carotenoids, a group of lipid-soluble pigments essential for eye health.
    Objective: Our aim was to evaluate carotenoid absorption and status in the context of hypobetalipoproteinemia.
    Methods: We first used knock-out Caco-2/TC7 cell models of FHBL-SD1 and FHBL-SD3 to evaluate carotenoid absorption. We then characterized FHBL-SD1 and FHBL-SD3 patient status in the main dietary carotenoids and compared it to that of control subjects.
    Results: In vitro results showed a significant decrease in basolateral secretion of α- and β-carotene, lutein, and zeaxanthin (-88.8 ± 2.2 % to -95.3 ± 5.8 %, -79.2 ± 4.4 % to -96.1 ± 2.6 %, -91.0 ± 4.5 % to -96.7 ± 0.3 % and -65.4 ± 3.6 % to -96.6 ± 1.9 %, respectively). Carotenoids plasma levels in patients confirmed significant deficiencies, with decreases ranging from -89 % for zeaxanthin to -98 % for α-carotene, compared to control subjects.
    Conclusion: Given the continuous loss in visual function despite fat-soluble vitamin treatment in some patients, carotenoid supplementation may be of clinical utility. Future studies should assess the correlation between carotenoid status and visual function in aging patients and investigate whether carotenoid supplementation could prevent their visual impairment.
    MeSH term(s) Humans ; Caco-2 Cells ; Zeaxanthins/metabolism ; Hypobetalipoproteinemias/genetics ; Carotenoids/metabolism ; Vitamins ; Lipids ; Monomeric GTP-Binding Proteins/genetics ; Syndactyly
    Chemical Substances Zeaxanthins ; Carotenoids (36-88-4) ; Vitamins ; Lipids ; SAR1B protein, human (EC 3.6.1.-) ; Monomeric GTP-Binding Proteins (EC 3.6.5.2)
    Language English
    Publishing date 2023-11-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2365061-8
    ISSN 1876-4789 ; 1933-2874
    ISSN (online) 1876-4789
    ISSN 1933-2874
    DOI 10.1016/j.jacl.2023.10.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Comparison of α-Tocopherol, α-Tocopherol Acetate, and α-Tocopheryl Polyethylene Glycol Succinate 1000 Absorption by Caco-2 TC7 Intestinal Cells.

    Cuerq, Charlotte / Bordat, Claire / Halimi, Charlotte / Blond, Emilie / Nowicki, Marion / Peretti, Noël / Reboul, Emmanuelle

    Nutrients

    2020  Volume 13, Issue 1

    Abstract: 1) Background: vitamin E is often supplemented in the form of tocopherol acetate, but it has poor bioavailability and can fail to correct blood tocopherol concentrations in some patients with severe cholestasis. In this context, α-tocopheryl ... ...

    Abstract (1) Background: vitamin E is often supplemented in the form of tocopherol acetate, but it has poor bioavailability and can fail to correct blood tocopherol concentrations in some patients with severe cholestasis. In this context, α-tocopheryl polyethylene glycol succinate 1000 (TPGS) has been of value, but very little is known about the mechanisms of its absorption. The aim of our work was to evaluate the mechanisms of absorption/secretion of TPGS compared to tocopherol acetate (TAC) and α-tocopherol by human enterocyte-like Caco-2 TC7 cells. (2) Methods: two weeks post-confluence Caco-2 cells were incubated with tocopherol- or TAC- or TPGS-rich mixed micelles up to 24 h and, following lipid extraction, TAC and tocopherol amounts were measured by high performance liquid chromatography (HPLC) in apical, cellular, and basolateral compartments. (3) Results: at equivalent concentrations of tocopherol in the apical side, the amounts of tocopherol secreted at the basolateral pole of Caco-2 cells are (i) significantly greater when the tocopherol is in the free form in the micelles; (ii) intermediate when it is in the TAC form in the micelles (
    MeSH term(s) Biological Availability ; Caco-2 Cells ; Dietary Supplements ; Humans ; Intestinal Absorption ; Intestinal Mucosa/cytology ; Intestinal Mucosa/metabolism ; Micelles ; Vitamin E/pharmacokinetics ; alpha-Tocopherol/pharmacokinetics
    Chemical Substances Micelles ; Vitamin E (1406-18-4) ; alpha-Tocopherol (H4N855PNZ1) ; tocophersolan (O03S90U1F2)
    Language English
    Publishing date 2020-12-31
    Publishing country Switzerland
    Document type Comparative Study ; Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu13010129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top